Augmiclave 625 mg
Pregnancy: No evidence of risk in humans. Lactation: Caution advised or effect undetermined. Contraindications: Penicillin hypersensitivity history of co-amoxiclav-associated or penicillin associated jaundice or hepatic dysfunction.
Infections of the respiratory tract ENT UTI skin and soft tissue.
Hepatitis cholestaticjaundice erythema multiforme (including Stevens-Johnson syndrome) toxic epidermal necrolysis exfoliative dermatitis vasculitis rarely
prolongation of bleeding time dizziness headache convulsions (particularly with high doses or in renal impairment) superficial staining of teeth with suspension
phlebitis at Injectionection site hypersensitivity reactions GI upset blood dyscrasias CNS effects antibiotic associated colitis.
Precautions: Hepatic impairment (monitor hepatic function). Risk of crystalluria with high doses patient should be well hydrated. Do not dilute Syrup below half-
strength. Renal impairment. Infectious mononucleosis. Risk of acute generalised exanthematous pustulosis (discontinue permanently).